Yusuf Yazici

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yusuf Yazici
    J Rheumatol 29:1586-9. 2002
  2. ncbi request reprint A mosaic of cells in a patient with systemic lupus erythematosus
    Daniel D Ricciardi
    Long Island College Hospital, Brooklyn, New York 11201, USA
    J Rheumatol 29:2014. 2002
  3. ncbi request reprint N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?
    Theodore Pincus
    J Rheumatol 34:250-2. 2007
  4. ncbi request reprint Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data
    Yusuf Yazici
    New York University Hospital for Joint Diseases, New York, New York, USA
    J Rheumatol 34:311-5. 2007
  5. pmc Safety and clinical efficacy of golimumab in the treatment of arthritides
    Ismail Simsek
    New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA
    Drug Healthc Patient Saf 2:169-80. 2010
  6. ncbi request reprint Early effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and Systemic Efficacy [ROSE] Study)
    Yusuf Yazici
    New York University Hospital for Joint Diseases, New York, USA
    Clin Exp Rheumatol 31:358-64. 2013
  7. ncbi request reprint Corticosteroids as disease modifying drugs in rheumatoid arthritis treatment
    Yusuf Yazici
    New York University Schoolof Medicine, NYU Hospital for Joint Diseases, 333 East 38th Street, New York, NY 10016, USA
    Bull NYU Hosp Jt Dis 70:11-3. 2012
  8. ncbi request reprint Treat-to-target: measures
    Yusuf Yazici
    New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA
    Clin Exp Rheumatol 30:S7-9. 2012
  9. ncbi request reprint Kinase inhibitors for the treatment of rheumatoid arthritis
    Yusuf Yazici
    Seligman Center, Department of Rheumatology and Medicine, NYU Hospital for Joint Diseases, 246 East 20th Street, Suite 101, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 70:204-7. 2012
  10. pmc Asymptomatic giant coronary aneurysm in an adolescent with Behcet's syndrome
    Philip J Kahn
    Department of Pediatrics, New York University Medical Center, 160 E, 32nd Street, New York, NY 10016, USA
    Pediatr Rheumatol Online J 10:2. 2012

Detail Information

Publications86

  1. ncbi request reprint Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yusuf Yazici
    J Rheumatol 29:1586-9. 2002
  2. ncbi request reprint A mosaic of cells in a patient with systemic lupus erythematosus
    Daniel D Ricciardi
    Long Island College Hospital, Brooklyn, New York 11201, USA
    J Rheumatol 29:2014. 2002
  3. ncbi request reprint N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?
    Theodore Pincus
    J Rheumatol 34:250-2. 2007
  4. ncbi request reprint Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data
    Yusuf Yazici
    New York University Hospital for Joint Diseases, New York, New York, USA
    J Rheumatol 34:311-5. 2007
    ..We compared patients with early rheumatoid arthritis (RA) of different ethnic/racial groups according to disease activity measures, to identify possible differences in patterns of severity of clinical status...
  5. pmc Safety and clinical efficacy of golimumab in the treatment of arthritides
    Ismail Simsek
    New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA
    Drug Healthc Patient Saf 2:169-80. 2010
    ..The real safety information will be available only once the drug has been used in many more patients, who frequently have comorbid conditions...
  6. ncbi request reprint Early effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and Systemic Efficacy [ROSE] Study)
    Yusuf Yazici
    New York University Hospital for Joint Diseases, New York, USA
    Clin Exp Rheumatol 31:358-64. 2013
    ..Tocilizumab has demonstrated efficacy in managing rheumatoid arthritis (RA) from week 2 onward. This sub-study assessed effects of tocilizumab plus disease-modifying anti-rheumatic drugs (DMARDs) during the first week of therapy...
  7. ncbi request reprint Corticosteroids as disease modifying drugs in rheumatoid arthritis treatment
    Yusuf Yazici
    New York University Schoolof Medicine, NYU Hospital for Joint Diseases, 333 East 38th Street, New York, NY 10016, USA
    Bull NYU Hosp Jt Dis 70:11-3. 2012
    ..We are much better positioned now then in earlier times to provide a good outcome for our patients, and every available tool needs to be considered and utilized for this purpose...
  8. ncbi request reprint Treat-to-target: measures
    Yusuf Yazici
    New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA
    Clin Exp Rheumatol 30:S7-9. 2012
    ..The main challenge remains getting all rheumatologists to start using one of these measures as part of the care they provide...
  9. ncbi request reprint Kinase inhibitors for the treatment of rheumatoid arthritis
    Yusuf Yazici
    Seligman Center, Department of Rheumatology and Medicine, NYU Hospital for Joint Diseases, 246 East 20th Street, Suite 101, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 70:204-7. 2012
    ..This review will go over the currently available data and discuss potential uses for these new agents...
  10. pmc Asymptomatic giant coronary aneurysm in an adolescent with Behcet's syndrome
    Philip J Kahn
    Department of Pediatrics, New York University Medical Center, 160 E, 32nd Street, New York, NY 10016, USA
    Pediatr Rheumatol Online J 10:2. 2012
    ..abstract:..
  11. pmc Abatacept versus other biologics in methotrexate inadequate responders with rheumatoid arthritis: you like tomato and I like tomahto... let's call the whole thing off
    Yusuf Yazici
    NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Arthritis Res Ther 14:104. 2012
    ..The decision to pick one over the other should focus on safety, long-term survival of the drug and ease of use, which is for the most part influenced by patient preferences...
  12. ncbi request reprint Monitoring response to treatment in rheumatoid arthritis--which tool is best suited for routine "real world" care?
    Yusuf Yazici
    New York University School of Medicine, New York, New York, USA
    Bull NYU Hosp Jt Dis 65:S25-8. 2007
    ..The tool that is easiest for both the patient and the physician to use and that still provides important treatment response and prognostic information has the best chance to be consistently and successfully applied by busy clinicians...
  13. doi request reprint Changing patterns of tumor necrosis factor inhibitor use in 9074 patients with rheumatoid arthritis
    Yusuf Yazici
    ew York University Hospital for Joint Diseases, New York, New York 10003, USA
    J Rheumatol 36:907-13. 2009
    ..We utilized a US insurance claims database to determine patterns of use such as dose escalation, time to discontinuation, and switching between TNF inhibitors in patients with RA...
  14. doi request reprint Behçet's syndrome
    Yusuf Yazici
    New York University School of Medicine, New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Curr Rheumatol Rep 12:429-35. 2010
    ..This is because of a lack of controlled studies evaluating such vascular, neurological, and gastrointestinal complications...
  15. ncbi request reprint Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations
    Y Yazici
    Department of Medicine, Division of Rheumatology, New York University, Hospital for Joint Diseases, USA
    Rheumatology (Oxford) 47:1054-7. 2008
    ..This in turn necessitates a discussion of the inadequacy of sample size (type II error) for identifying harm. This is particularly important in RCTs of TNF inhibitors as harm related to these agents is still a matter of debate...
  16. ncbi request reprint Informed consent--practical considerations
    Yusuf Yazici
    NYU Hospital for Joint Diseases, NYU Langone Medical Center, New York, New York, USA
    Bull NYU Hosp Jt Dis 68:127-9. 2010
    ..Transparency is important for the maintenance of high standards in clinical research and for public trust of the process, a sometimes underrecognized factor in healthcare initiatives...
  17. ncbi request reprint Vasculitis update, 2007
    Yusuf Yazici
    New York University School of Medicine, and Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 65:212-4. 2007
    ..New medications and new ways of using old medications have provided us with new therapies to treat our patients. This review focuses on recent date that may have an impact on the way vasculitis is treated...
  18. ncbi request reprint Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy
    Yusuf Yazici
    New York University School of Medicine, NY, USA
    Bull NYU Hosp Jt Dis 66:77-85. 2008
    ..However, the extent to which these agents are used in current clinical practice in the United States (U.S.) has not been systematically evaluated...
  19. ncbi request reprint Some concerns about adverse event reporting in randomized clinical trials
    Yusuf Yazici
    New York University School of Medicine, NY, USA
    Bull NYU Hosp Jt Dis 66:143-5. 2008
    ....
  20. ncbi request reprint Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis
    Y Yazici
    New York University, Hospital for Joint Diseases, New York, USA
    Clin Exp Rheumatol 26:449-52. 2008
    ..We surveyed how TNF inhibitors performed in randomized controlled trials when compared to methotrexate in methotrexate naive rheumatoid arthritis patients...
  21. pmc Informed consent: time for more transparency
    Yusuf Yazici
    New York University School of Medicine, NYU Hospital for Joint Diseases, 246 East 20th Street, New York, NY 10003, USA
    Arthritis Res Ther 12:121. 2010
    ..Informed consent is not currently part of the clinical trial registries. For purposes of full disclosure to the patients and the public, the informed consent should be part of the required documents for such registries...
  22. ncbi request reprint Systemic vasculitis treatment and monitoring update, 2008
    Yusuf Yazici
    New York University School of Medicine, New York, NY, USA
    Bull NYU Hosp Jt Dis 66:228-30. 2008
    ..This review will focus on recently published data that could have an impact on the way we treat systemic vasculitis patients...
  23. ncbi request reprint Patient and physician perception of the infusion process of the biologic agents abatacept, infliximab, and rituximab for the treatment of rheumatoid arthritis
    Y Yazici
    NYU Hospital for Joint Diseases, 246 East 20th Street, Suite 101, New York, NY 10003, USA
    Clin Exp Rheumatol 27:907-13. 2009
    ..To assess the process related to each infusible biologic used in rheumatoid arthritis (RA) with regard to patient and physician engagement in the infusion process, ancillary services required, and participant preferences...
  24. ncbi request reprint Safety reporting in randomized clinical trials - a need for improvement
    Yusuf Yazici
    New York University School of Medicine, New York, NY, USA
    Bull NYU Hosp Jt Dis 67:209-10. 2009
    ....
  25. ncbi request reprint Long-term safety of methotrexate in the treatment of rheumatoid arthritis
    Y Yazici
    New York University School of Medicine, NYU Hospital for Joint Diseases, Seligman Center for Advanced Therapeutics, New York, NY, USA
    Clin Exp Rheumatol 28:S65-7. 2010
    ..Better information on the effectiveness and safety of weekly-low dose MTX should be communicated to all health professionals involved in the management of RA patients...
  26. ncbi request reprint Monitoring outcomes of arthritis and longitudinal data collection in routine care using a patient questionnaire that incorporates a clinical note on one piece of paper
    Yusuf Yazici
    New York University, Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003, USA
    Best Pract Res Clin Rheumatol 21:629-36. 2007
    ..Rheumatologists would find it valuable to adapt questionnaires to the care they provide for all their patients, to document and improve the care they provide, and add quantitative data to standard clinical care...
  27. pmc A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors
    Y Yazici
    New York University, Hospital for Joint Diseases, New York, New York, USA
    Ann Rheum Dis 66:124-7. 2007
    ..The adequacy of reporting the time element in adverse effects in articles on randomised clinical trials of cyclo-oxygenase-2 and tumour necrosis factor (TNF)alpha antagonists was surveyed...
  28. ncbi request reprint Treatment options for rheumatoid arthritis beyond TNF-α inhibitors
    Yusuf Yazici
    1New York University School of Medicine, Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases, 246 East 20th Street, New York, NY 10003, USA
    Expert Rev Clin Pharmacol 3:663-6. 2010
    ..Abatacept is also currently used as a first-line biologic and others can also be used once data are available...
  29. ncbi request reprint Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yusuf Yazici
    New York University School of Medicine, New York, NY, USA
    Bull NYU Hosp Jt Dis 65:300-5. 2007
    ....
  30. doi request reprint Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
    Yusuf Yazici
    New York University Hospital for Joint Diseases, New York, USA
    Ann Rheum Dis 71:198-205. 2012
    ..To evaluate efficacy of tocilizumab in US patients with moderate to severe active rheumatoid arthritis (RA) and inadequate clinical response to disease-modifying antirheumatic drugs (DMARD). Safety-related outcomes were also analysed...
  31. ncbi request reprint Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: a post hoc analysis of randomized clinical trial data
    Y Yazici
    NYU University Hospital for Joint Diseases, New York, NY, USA
    Clin Exp Rheumatol 29:494-9. 2011
    ....
  32. ncbi request reprint Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events
    Yusuf Yazici
    The Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York, USA
    Arthritis Rheum 48:2769-72. 2003
    ....
  33. ncbi request reprint A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health a
    Theodore Pincus
    NYU Hospital for Joint Diseases, 301 East 17 Street, New York, NY 10003, USA
    Best Pract Res Clin Rheumatol 21:789-804. 2007
    ..01-2), 'moderate severity' (2.01-4), and 'high severity' (>4). RAPID scoring is feasible in standard clinical care to support continuous quality improvement...
  34. ncbi request reprint Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate
    Yusuf Yazici
    Brooklyn Heights Arthritis Associates, Long Island College Hospital, Brooklyn, New York, USA
    J Rheumatol 31:1723-6. 2004
    ..To compare the level of morning stiffness in a cohort of patients with early rheumatoid arthritis (RA), assessed on a self-report questionnaire, to levels of patient self-report scores and clinical and laboratory variables...
  35. ncbi request reprint RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories
    Theodore Pincus
    New York University Hospital for Joint Diseases, New York, New York 10003, USA
    J Rheumatol 35:2136-47. 2008
    ....
  36. ncbi request reprint MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter
    Theodore Pincus
    Division of Rheumatology, NYU Hospital for Joint Diseases, 301 East 17th Street, Room 1608, New York, New York 10003, USA
    Bull NYU Hosp Jt Dis 70:177-86. 2012
    ....
  37. doi request reprint Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials
    Theodore Pincus
    Division of Rheumatology, Department of Medicine, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY 10003, USA
    J Rheumatol 38:2565-71. 2011
    ..RAPID3 is correlated significantly with DAS28, but calculated in 5-10 seconds on a Multidimensional Health Assessment Questionnaire (MDHAQ), compared to 114 seconds for DAS28...
  38. ncbi request reprint RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases
    Theodore Pincus
    New York University School of Medicine, New York, NY, USA
    Bull NYU Hosp Jt Dis 67:211-25. 2009
    ..RAPID3 vital signs can contribute to this synthesis toward improved quality, outcomes, and documentation of rheumatology care...
  39. ncbi request reprint Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy
    Doruk Erkan
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York, USA
    Arthritis Rheum 47:285-90. 2002
    ..To conduct a pilot study to identify rheumatologists' treatment preferences for first-line rheumatoid arthritis (RA) therapy and determine whether pharmacoeconomic variables modify physician choice(s)...
  40. doi request reprint RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care
    Theodore Pincus
    Division of Rheumatology, Department of Medicine, New York University School of Medicine and NYU Hospital for Joint Diseases, Room 1608, 301 East 17th Street, New York, NY 10003, USA
    Rheum Dis Clin North Am 35:773-8, viii. 2009
    ..In all rheumatic diseases RAPID3 is able to provide a baseline quantitative value, and to quantitatively monitor and document improvement or worsening over time...
  41. ncbi request reprint Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores
    Yusuf Yazici
    New York University Hospital for Joint Diseases, New York, New York 10003, USA
    J Rheumatol 35:603-9. 2008
    ..The measures studied were a 28-Joint Count, Disease Activity Score (DAS), Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and various Routine Assessment of Patient Index Data (RAPID) scores derived from the MDHAQ...
  42. doi request reprint RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damag
    Theodore Pincus
    New York University School of Medicine and New York University Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003, USA
    Arthritis Care Res (Hoboken) 63:1142-9. 2011
    ....
  43. ncbi request reprint Treat-to-target: not as simple as it appears
    Theodore Pincus
    Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY 1003, USA
    Clin Exp Rheumatol 30:S10-20. 2012
    ....
  44. ncbi request reprint Promising new treatments for rheumatoid arthritis - the kinase inhibitors
    Yusuf Yazici
    Division of Rheumatology and Medicine, NYU Hospital for Joint Diseases, New York, New York, USA
    Bull NYU Hosp Jt Dis 69:233-7. 2011
    ..This paper will review some of the relevant published data for these agents and discuss where they may be placed in our treatment options for RA...
  45. ncbi request reprint Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations
    Theodore Pincus
    NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Best Pract Res Clin Rheumatol 21:601-28. 2007
    ..More attention to measures for use in standard care could improve care and outcomes for patients with rheumatic diseases...
  46. ncbi request reprint Beyond RAPID3 - practical use of the MDHAQ to improve doctor-patient communication
    Theodore Pincus
    New York University School of Medicine, New York, NY, USA
    Bull NYU Hosp Jt Dis 68:223-31. 2010
    ..routine Assessment of Patient Index Data 3 (RAPID3) scores are recorded in the medical record and entered into a flowsheet, which also includes other MDHAQ scores, laboratory tests, and medications...
  47. doi request reprint Complex measures and indices for clinical research compared with simple patient questionnaires to assess function, pain, and global estimates as rheumatology "vital signs" for usual clinical care
    Theodore Pincus
    Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, Room 1608, 301 East, 17th Street, New York, NY 10003, USA
    Rheum Dis Clin North Am 35:779-86, ix. 2009
    ..Differences between complex measures for research and simple questionnaires designed for usual clinical care might be more widely recognized, to promote quantitative measurement in the infrastructure of usual rheumatology care...
  48. ncbi request reprint A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers
    Theodore Pincus
    NYU Hospital for Joint Diseases, 301 East 17 Street, New York, NY 10003, USA
    Best Pract Res Clin Rheumatol 21:755-87. 2007
    ..This chapter provides a brief tutorial designed to instruct rheumatologists and their staffs regarding how to use and score the MDHAQ and RAPID in standard clinical care...
  49. doi request reprint RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than
    Theodore Pincus
    New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Arthritis Care Res (Hoboken) 62:181-9. 2010
    ....
  50. doi request reprint Quality control of a medical history: improving accuracy with patient participation, supported by a four-page version of the multidimensional health assessment questionnaire (MDHAQ)
    Theodore Pincus
    Division of Rheumatology, Department of Medicine, New York University School of Medicine and NYU Hospital for Joint Diseases, Room 1608, 301 East 17th Street, New York, NY 10003, USA
    Rheum Dis Clin North Am 35:851-60, xi. 2009
    ..This procedure engenders a more accurate patient history with no effort on the part of the physician, saving time for the physician and improving the quality of the medical record...
  51. ncbi request reprint Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
    Doruk Erkan
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York, USA
    Arthritis Rheum 56:2382-91. 2007
    ....
  52. ncbi request reprint Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data
    Theodore Pincus
    NYU Hospital for Joint Diseases, New York, New York 10003, USA
    J Rheumatol 35:1550-8. 2008
    ....
  53. doi request reprint Behcet's Syndrome
    Sam R Dalvi
    Division of Rheumatology, Duke University Medical Center, Durham, NC, USA
    Drugs 72:2223-41. 2012
    ..Finally, we conclude with treatment strategies for the common manifestations of BS along with a discussion of the management of thrombotic disease in these patients...
  54. doi request reprint Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis
    Isabel Castrejón
    New York University School of Medicine and NYU Hospital for Joint Diseases, NY 10003, USA
    Arthritis Care Res (Hoboken) 65:288-93. 2013
    ....
  55. doi request reprint Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations
    Yusuf Yazici
    Division of Rheumatology, Department of Medicine, New York University School of Medicine and New York University Hospital for Joint Diseases, Room 1608, 301 East 17th Street, New York, NY 10003, USA
    Rheum Dis Clin North Am 35:723-9, vi. 2009
    ..Whereas prevention of radiographic progression is certainly desirable, it appears that prevention of functional disability is far more important for successful patient outcomes...
  56. doi request reprint Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study
    Susan J Lee
    Veterans Affairs San Diego Healthcare System, and University of California, San Diego, Department of Medicine, San Diego, California, USA
    J Rheumatol 36:1611-7. 2009
    ..To determine whether these findings have altered practice patterns, we used the Consortium of Rheumatology Researchers of North America (CORRONA) registry to assess the pattern of TNF inhibitor utilization in the US over time...
  57. ncbi request reprint Necrotizing vasculitis--a 2009 update
    Pamela H Sharaf
    Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, New York, USA
    Bull NYU Hosp Jt Dis 67:303-5. 2009
    ..In addition, Behcet's syndrome appears to be more common than previously assumed and is likely more common than a combination of ANCA-associated vasculitis (AAV) syndromes...
  58. ncbi request reprint Biologics in development for rheumatoid arthritis: relevance to osteoarthritis
    Steven B Abramson
    New York University School of Medicine, Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003, USA
    Adv Drug Deliv Rev 58:212-25. 2006
    ....
  59. doi request reprint An audit of Behcet's syndrome research: a 10-year survey
    Fehim Esen
    Cerrahpasa Medical Faculty and Division of Rheumatology, Istanbul University, Turkey
    J Rheumatol 38:99-103. 2011
    ..We reason that recognizing such methodological shortcomings will lead to better quality clinical and basic science articles...
  60. pmc Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis
    Jeffrey D Greenberg
    New York University Hospital for Joint Diseases, New York, NY Electronic address
    Am J Med 126:1089-98. 2013
    ..We compared disease activity and clinical outcomes across racial and ethnic groups using data from a large, contemporary US registry...
  61. ncbi request reprint Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care
    Theodore Pincus
    Department of Medicine, Division of Rheumatology, NYU Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 70:30-6. 2012
    ..All rheumatologists may include MDHAQ/RAPID3 in all patients in the infrastructure of clinical care...
  62. ncbi request reprint Are excellent systematic reviews of clinical trials useful for patient care?
    Theodore Pincus
    Department of Medicine, Division of Rheumatology, New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Nat Clin Pract Rheumatol 4:294-5. 2008
  63. doi request reprint Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure
    Theodore Pincus
    Division of Rheumatology, Department of Medicine, New York University School of Medicine and NYU Hospital for Joint Diseases, 301 East 17th Street, Room 1608, New York, NY 10003, USA
    Rheum Dis Clin North Am 35:687-97, v. 2009
    ..Further elucidation of these differences may be informative in efforts to advance quantitative scientific patient assessment and management in rheumatic diseases, with improved patient outcomes...
  64. doi request reprint Patient questionnaires in rheumatoid arthritis: advantages and limitations as a quantitative, standardized scientific medical history
    Theodore Pincus
    Division of Rheumatology, Department of Medicine, New York University School of Medicine and NYU Hospital for Joint Diseases, Room 1608, 301 East 17th Street, New York, NY 10003, USA
    Rheum Dis Clin North Am 35:735-43, vii. 2009
    ..Patient questionnaires are useful to monitor patient status in usual clinical care, with almost no effort on the part of the physician and staff if distributed by the receptionist in the infrastructure of office practice...
  65. ncbi request reprint Prospects for disease modification in osteoarthritis
    Steven B Abramson
    New York University Hospital for Joint Diseases, New York, NY 10003, USA
    Nat Clin Pract Rheumatol 2:304-12. 2006
    ..The challenges to drug development and the obstacles to disease modification strategies will also be addressed...
  66. ncbi request reprint Databases in routine care: possible and necessary
    Yusuf Yazici
    New York University School of Medicine, NYU Hospital for Joint Diseases, New York, NY, USA
    Bull NYU Hosp Jt Dis 65:127-31. 2007
    ..Data that are feasible to collect during clinical care provide the optimal approach to quantitatively assess how patients are doing...
  67. ncbi request reprint Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis
    Rosemary Adamson
    From the Division of Pulmonary and Critical Care Medicine, University ofWashington School of Medicine, Seattle, WA and Department of Rheumatology and Division of Cardiology, New York University Division of Rheumatology, Department of Medicine, St Luke s Roosevelt Hospital Center and Division of Pulmonary, Critical Care and Sleep Medicine, New York University, New York, NY
    J Clin Rheumatol 19:386-9. 2013
    ..Autopsy demonstrated necrotizing eosinophilic myocarditis. This is a rare cause of fulminant heart failure. This is the first report of a TNF-α antagonist potentially associated with acute necrotizing eosinophilic myocarditis. ..
  68. doi request reprint Criteria for Behçet's disease with reflections on all disease criteria
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey Electronic address
    J Autoimmun 48:104-7. 2014
    ..We first have to reconcile with ourselves that probabilities are very important in our practice and research. Moreover that reconciliation must also be shared with the public, which includes our patients...
  69. ncbi request reprint Monitoring outcomes of arthritis and longitudinal data collection using patient questionnaires in routine care
    Yusuf Yazici
    NYU Hospital for Joint Diseases, 301 East 17th Street, New York, New York 10003, USA
    Bull NYU Hosp Jt Dis 64:40-4. 2006
    ..Consistent use of patient questionnaires and systematic storage of the information gained can help document, track, and improve patient care in routine rheumatology practice...
  70. ncbi request reprint The role of cardiac magnetic resonance imaging in antiphospholipid syndrome
    Doruk Erkan
    Division of Rheumatology, Hospital for Special Surgery, New York, NY 10021, USA
    J Rheumatol 29:2658-9. 2002
  71. ncbi request reprint Pregnancy outcomes following total hip arthroplasty: a preliminary study and review of the literature
    Yusuf Yazici
    Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA
    Orthopedics 26:75-6. 2003
    ..This is the first study that provides a patient-based assessment of pregnancy outcomes and delivery in women who underwent THA. The preliminary data suggest THA had no adverse effect on subsequent childbearing...
  72. doi request reprint American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
    Kenneth G Saag
    University of Alabama, Birmingham, AL, USA
    Arthritis Rheum 59:762-84. 2008
  73. ncbi request reprint Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al
    Yusuf Yazici
    Arthritis Rheum 54:3061-2. 2006
  74. ncbi request reprint Interleukin-6 inhibition--tolerability profile and clinical implications
    Vibeke Strand
    Division of Immunology, Stanford University School of Medicine, Palo Alto, California, USA
    Bull NYU Hosp Jt Dis 65:S21-4. 2007
    ..The true implications of these signals in RCTs must be addressed in larger numbers of RA patients with longer term exposure before firm conclusions are reached...
  75. ncbi request reprint Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al
    Theodore Pincus
    Arthritis Rheum 52:4044-5; author reply 4045-7. 2005
  76. ncbi request reprint Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials
    Theodore Pincus
    J Rheumatol 33:2372-5. 2006
  77. ncbi request reprint Denosumab in postmenopausal women with low bone mineral density
    Julie Schwartzman
    N Engl J Med 354:2390-1; author reply 2390-1. 2006
  78. ncbi request reprint Use of statistical analysis in open extension studies
    Yusuf Yazici
    J Rheumatol 33:437; author reply 437-8. 2006
  79. ncbi request reprint Saving time and improving care with a multidimensional health assessment questionnaire: 10 practical considerations
    Theodore Pincus
    Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232 4500, USA
    J Rheumatol 33:448-54. 2006
  80. doi request reprint Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study
    Tuulikki Sokka
    Jyvaskyla Central Hospital, Jyvaskyla, Finland
    Arthritis Rheum 59:42-50. 2008
    ..We studied the prevalence of physical activity and associations with demographic and disease-related variables in patients with RA from 21 countries...
  81. pmc Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
    Antonio Naranjo
    Hospital de Gran Canaria Dr, Negrin, University of Las Palmas de Gran Canaria, Barranco de la Ballena s n 35011, Spain
    Arthritis Res Ther 10:R30. 2008
    ....
  82. ncbi request reprint Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies: comment on the article by Sairam et al
    Doruk Erkan
    Clin Rheumatol 22:493. 2003
  83. ncbi request reprint Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus
    Yusuf Yazici
    Arthritis Rheum 48:3611; author reply 3613-5. 2003